MedPath

Replace Glycemic Load and Satiety Study

Phase 1
Completed
Conditions
Glycemic Index
Glucose Blood
Interventions
Other: Medium GL 76
Other: Low GL 48
Other: High GL 107
Other: Medium GL 68
Registration Number
NCT01516333
Lead Sponsor
Pennington Biomedical Research Center
Brief Summary

The study is to examine the effect of four diets differing in glycemic index and amount of carbohydrate on blood sugar and insulin and in hunger, satiety, and vigor.

Detailed Description

The extent to which a food raises blood sugar after its consumption is ranked using the Glycemic Index (GI). Foods with a high GI are those taht cause a large and rapid rise in blood sugar while those with a low GI produce small fluctuations in blood sugar. It is believed that low GI foods are advantageous for health since the swings in blood sugar and insulin resistant or diabetic. Interestingly, some studies suggest that low GI food make you less hungry and that this may play an important role in body weight regulation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Body Mass index between 25-35 kg/m2
  • Fasting serum glucose
  • Fasting serum glucose < 125 mg/dl
  • Free of chronic disease
  • Willing to eat only the foods that are provided by the Center during the diet periods
  • Willing to abstain from the consumption of alcohol during the diet periods
  • Regularly cycling and willing not to become pregnant using birth control (abstinence, barrier methods, partner surgically sterile
  • Monophasic birth control (same dose each day)
  • Hormone replacement therapy
  • Post-menopausal (over 1 year without bleeding)
  • Have had partial hysterectomy over the age of 55
  • complete hysterectomy at any age
Exclusion Criteria
  • Documented presence of atherosclerotic disease
  • Diabetes mellitus
  • Renal, hepatic, endocrine, gastrointestinal, hematological or other systemic disease
  • Body Mass Index <25 or > 35
  • History of drug or alcohol abuse in the last year
  • For women, pregnancy, breast feeding or postpartum < 6 months
  • History of depression or mental illness requiring treatment or medication within that last 6 months
  • Multiple food allergies or significant food preferences or restrictions that would interfere with diet adherence
  • Lifestyle or schedule incompatible with the study protocol
  • Planned continued use of dietary supplements through the study trial
  • Smoking or tobacco use

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Diet 2Medium GL 76High GI, Low Carb, Med GL
Diet 4Low GL 48Low GI, Low Carb, Low GL
Diet 1High GL 107High GI; High Carb; High GL
Diet 3Medium GL 68Low GI, High Carb, Med GL
Primary Outcome Measures
NameTimeMethod
Blood Glucose over time1 month

Blood glucose demonstrates that diets of different glycemic load result in measurable differences in serum glucose and insulin.

Secondary Outcome Measures
NameTimeMethod
Visual Analog scores (VAS)1 month

Hunger, satiety, and vigor will be measured by the visual analog scales.

Trial Locations

Locations (1)

Pennington Biomedical Research Center

🇺🇸

Baton Rouge, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath